10.1016/j.remn.2010.08.005 51 European Medicines Agency (2012)
Mitochondriacytoskeleton interactions in the sperm midpiece
It is prescribed to patients with obesity (body mass index of 30 or more) and overweight (body mass index of 27 or more) with a weight-related condition like cardiovascular disease, high blood pressure, or type 2 diabetes
The medicine also affects satiety, allowing patients to feel full after eating, the Cleveland Clinic said
The phase 2 trial reported that GI events were the most common adverse effects across all dose groups, and they were dose-dependent, meaning they increased in frequency and severity as the dose went up
This multifaceted approach not only aids in blood sugar management but also contributes to significant weight loss in many patients, making Ozempic a powerful tool in the fight against diabetes and obesity